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S U M M A R Y
Background: Dengue is the most important vector-borne disease in many different parts of the world and
is expanding into other areas of the globe without hindrance. The morbidity and mortality due to dengue
complications are increasing globally at an alarming rate. Although transmission of the dengue virus has
been documented in well-characterized areas of Pakistan, its incidence in Khyber Pakhtunkhawa has not
been characterized. To address this issue we aimed to determine the seroprevalence of dengue (IgM and
IgG) antibodies and the disease symptoms in the population of Khyber Pakhtunkhawa, and to investigate
the incidence of dengue fever in different seasons and in urban as well as in rural areas.
Methods: From August to October 2011, data of suspected dengue patients were collected from different
primary, secondary, and tertiary collection centers situated in Khyber Pakhtunkhawa in order to
determine the actual seroprevalence of dengue antibodies (IgM and IgG) in Khyber Pakhtunkhawa.
Results: A total 612 subjects with a suspected infection were enrolled in our study. Of the 612 suspected
cases, 319 were found positive for dengue IgG, IgM, or both IgG and IgM. The overall weighted prevalence
of dengue-speciﬁc antibodies (IgM and/or IgG) was 52.12%. Overall, of the 52.12%, 31.86% (95%
conﬁdence interval (CI) 28.17–35.55) were positive for dengue IgM and 20.26% (95% CI 17.03–23.39)
were positive for dengue IgG. Only 23 (3.75%) samples showed both IgG and IgM antibodies. A higher
prevalence of IgM (39.35%, 95% CI 32.84–45.86) and IgG (22.42%, 95% CI 16.86–27.98) antibodies was
found in the age group 21–30 years as compared to the children age group (10 years) and the oldest age
group (51 years). The mean age of the febrile cohort was 53.16  44.22 years, ranging from 4 to 85 years.
Age group was not statistically associated with IgM (p = 0.64) or IgG (p = 0.49) positivity. A higher
seroprevalence of IgM (37.24%, 95%CI 32.84–45.86) was observed in males as compared to females (IgM
17.88%, 95% CI 11.11–24.65) while higher seroprevalnce of IgG (22.76%, 95% CI 15.35–30.17) was seen in
females as compared to males (IgG 17.58%, 95% CI 14.21–20.95). Gender was not signiﬁcantly associated with
IgM (p = 0.06) or IgG (p = 0.53) positivity. Dengue IgM (35.38%, 95% CI 38.61–62.91) and IgG (50.76%, 95% CI
38.61–62.91) were higher in patients who had a history of travel to a dengue endemic area as compared to
those who did not (IgM 33%, 95% CI 29.06–36.94, and IgG 15%, 95% CI 12.01–17.99). History of travel to an
endemic area was signiﬁcantly associated with IgM (p = 0.023) and IgG (p = 0.041) positivity. A higher
incidence of IgM (41.13%, 95% CI 35.55–46.71) and IgG (27.42%, 95% CI 22.36–32.48) was observed in urban
areas than in rural areas (IgM 23%, 95% CI 18.34– 27.66, and IgG 13.41%, 95% CI 9.63–17.19). IgM (p = 0.0005)
and IgG (p = 0.0007) positivity was signiﬁcantly associated with area of residence. Symptoms including fever
(p = 0.007), headache (p = 0.001), Skin rash (0.005), joint pain (0.004) and Fatigue were signiﬁcantly linked to
dengue fever. IgM and IgG antibodies were more frequently seen in the post-monsoon season (68.33%) than
in the monsoon period (31.68%). The death ratio in the overall weighted prevalence was 2.19%.
Conclusion: The results of the present cohort study of febrile subjects show that young people and males
are more susceptible to dengue fever. Dengue infection was most prominent in the post-monsoon
season, in urban areas, and in patients with a history of travel to an endemic locality. Furthermore seven
deaths were found in our cohort study.
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Dengue is a most signiﬁcant febrile illness caused by a single
stranded an enveloped RNA virus belongs to the family Flaviviridae,
genus Flavivrus.1 Dengue infection is caused by any one of four
distinctive antigenically related dengue virus serotypes: DENV-1,
DENV-2, DENV-3, and DENV-4.2 Medical manifestations of dengue
infection range from asymptomatic, to mild ﬂu-like symptoms, to
severe life-threatening dengue complications such as dengue shock
syndrome (DSS) and dengue hemorrhagic fever (DHF).3,4 The dengue
virus is transmitted to humans through the bite of an infected
mosquito of the genus Aedes (namely Aedes aegypti and Aedes
albopictus) during daylight hours.5 An estimated 50–100 million
cases of dengue fever (DF), 250 000–500 000 of DHF, and 25 000
deaths occur each year globally.6 Frequent international/national
travel and trade can lead to the movement of viruses and mosquitoes
from one part of the globe to another, increasing the risk of
epidemics.7 Both viral and host factors are thought to contribute to
the manifestations of the disease in each infected person.8
Since the ﬁrst isolation of the dengue virus in Japan in 1943, it
has been active sporadically in different parts of the world;
however in the last decade, major outbreaks of this highly endemic
virus were seen in many subcontinents.9 The earliest well-known
outbreak of DHF occurred in the city of Manila, Philippines in
1953–1954. It has now been transmitted geographically from
Southeast Asian states to Asian states including Sri Lanka, India,
and Pakistan.10
The ﬁrst case of DHF in Pakistan was reported in 1994,11 and
since then its prevalence has increased rapidly. It frequently affects
the older age groups, with the adult to child ratio being 3.3:1.12
Pakistan was considered a non-endemic country until 1993, but is
now considered endemic for dengue.11
In 2005 an outbreak of dengue with DENV-3 serotype was
documented in Karachi;13 in the same area, Khan and colleagues
found co-circulation of serotypes DENV-2 and DENV-3 and
concluded that dengue is now hyperendemic in Pakistan.14 More
recently, Fatima et al. reported that the most frequent serotypes of
the dengue virus circulating in the country are DENV-2 and DENV-
3. The reported principal genotypes described were subtype IV of
DENV-2 and subtype III of DENV-3.15
Although Pakistan has a history of outbreaks of dengue viral
infection, reported from districts, towns, and cities,11,14–18 not a
single dengue outbreak has been reported from Khyber Pakhtun-
khawa Province. To address this issue we aimed to evaluate the
seroprevalence of dengue antibodies (IgM and IgG) and the clinical
symptoms of the disease in the population of Khyber Pakhtun-
khawa, and to investigate the incidence of dengue fever in the
different seasons and in urban as well as in rural areas. The study
design and questionnaire were approved by the ethics committee
of the university.
2. Materials and methods
2.1. Study area
Khyber Pakhtunkhawa, formerly known as the North-West
Frontier Province (NWFP), is located in the north-west of Pakistan
and is one of the four provinces of the country. It shares boundaries
with Afghanistan to the north-west, Federal Administrative Tribal
Areas (FATA) to the west and south, Gilgit-Baldistan to the north-
east, Azad Jammu and Kashmir to the east, Balochistan to the
south, and Islamabad Capital Territory and Punjab to the south-
east (Figure 1). Khyber Pakhtunkhawa is the third most important
populated territory of the country. Pakhtuns form the major part of
the population, followed by smaller groups such as Hindkowans,
Gujjars, Chatralis, and Dards. In this study we evaluated theseroprevalence of IgM and IgG dengue antibodies speciﬁcally in the
population of Khyber Pakhtunkhawa.
2.2. Data collection
Data were collected from different primary, secondary, and
tertiary collection centers situated in Khyber Pakhtunkhawa,
Pakistan. The data were obtained from records and registers/ﬁlled
forms, and a questionnaire was administered to obtain information
including the patient’s gender, clinical manifestations, area of
residence, admission date, and their history of travel to endemic
areas of the country. A total of 612 patients with a suspected
infection were selected for the study; 489 (79.90%) were males and
123 (20.09%) were females. Brieﬂy, 3 ml of venous blood were
collected aseptically then labeled and processed at the different
diagnostic centers. The blood was centrifuged at 3000 rpm for
5 min and the serum was used for the detection of IgG and IgM
antibodies against dengue virus using a highly sensitive ELISA kit
(Diagnostic Automation, Cortez Diagnostics Inc., CA, USA) in
accordance with the manufacturer’s protocol. The speciﬁcity and
sensitivity of the IgG ELISA kit are 96% and 100%, respectively, and
of the IgM ELISA kit are 100% and 86%, respectively.
2.3. Statistical analysis
The data analysis was done using SPSS v. 16 software. Chi-
square analysis was used to determine the relationship between
gender, age group, history of travel to an endemic area, and area of
residence (urban or rural) and dengue IgM and IgG seroprevalence.
Logistic regression analysis was done to investigate various factors
related to a positive dengue IgM and IgG. A p-value of <0.05 was
considered statistically signiﬁcant.
3. Results
Sum of 612 dengue suspected subjects were enrolled in this
setup. Of the 612 suspected cases, 319 were seen positive for
dengue IgG, IgM, or both IgG and IgM. The entire weighted
prevalence of dengue-speciﬁc antibodies (IgM and/or IgG) was
52.12%. Overall, of the 52.12%, 31.86% (95% conﬁdence interval (CI)
28.17–35.55) were positive for dengue IgM and 20.26% (95% CI
17.03–23.39) were positive for dengue IgG. Only 23 (3.75%)
samples showed both IgG and IgM antibodies.Mean age of febrile
cohort was 53.16  44.22 years ranging from 4 years to 85 years
older.
3.1. Distribution of dengue fever by gender in the different districts of
Khyber Pakhtunkhawa
Serum was collected from 612 suspected dengue patients
from the following districts: Peshawar (n = 148), Mansehra
(n = 61), Abbottabad (n = 59), Mardan (n = 64), Nowshera
(n = 37), Swat (n = 24), Kohat (n = 31), Dir (lower) (n = 22),
Haripur (n = 29), Charsadda (n = 24), Shangla (n = 33), Bannu
(n = 27), Karak (n = 21), Swabi (n = 15), and Dera Ismail khan
(n = 17). A total of 319 (52.12%) samples were found ELISA-
positive for dengue antibodies: 195 IgM (31.86%) and 124 IgG
(20.26%). The highest seropositivity of IgM and IgG was reported
from the district of Peshawar (n = 93, 29.15%), followed by
Mansehra (n = 40, 12.5%), Abbottabad (n = 39, 12.2%), Mardan
(n = 38, 11.9%), Nowshera (n = 17, 5.32%), Swat (n = 14, 4.38%),
Kohat (n = 13, 4%), Dir (lower) (n = 13, 4%), Haripur (n = 12,
3.76%), Charsadda (n = 10, 13.13%), Shangla (n = 8, 2.50%), Bannu
(n = 7, 2.19%), Karak (n = 6,1.88%), Swabi (n = 5,1.56%),and Dera
Ismail Khan (n = 4, 1.25%) (Figure 2).
Figure 1. Geographical representation of Khyber Pakhtunkhawa adopted from (http://yusufzai.blogspot.com/2010/02/from-nwfp-to-pakhtunkhwa.html).
Figure 2. Distribution of dengue fever in different districts of Khyber
Pakhtunkhawa.
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dengue patients of Khyber Pakhtunkhawa
Out of the 612 study subjects, 31.86% (95% conﬁdence
interval (CI) 28.17–35.55) were found to be IgM-positive
(primary infection). The most prevalent incidence of IgM
antibodies was observed in males (37.24%, 95% CI 32.96–
41.52), compared to females (17.88%, 95% CI 11.11–24.65); no
signiﬁcant association was seen for IgM-positive subjects and
gender (p = 0.06). The incidence of IgM antibodies was high in
the age group of 21–30 years (39.35%, 95% CI 32.84–45.86)
compared to the children age group 10 years and older people
aged 51 years. No statistical relationship was observed
between IgM-positive subjects and age groups (p = 0.64). The
seroprevalence of IgM antibodies in infected patients was
highest in urban areas (41.13, 95% CI 35.55–46.71) as compared
to rural areas (23%, 95% CI 18.34–27.66). Area of residence was
statistically associated with dengue infection (p = 0.0005). Most
of the IgM antibodies were found positive in patients with a
history of travel to an endemic area (35.38%, 95% CI 23.76–47) as
compared to the distribution of IgM in diseased subjects with no
history of travel to an endemic area (33%, 95% CI 29.06–36.94).
Travel history was strongly associated with IgM-positive
subjects (p = 0.023) (Table 1).3.3. Dengue fever conﬁrmation by IgG and selected variables in
dengue patients of Khyber Pakhtunkhawa
Out of the 612 study subjects, 20.21% (95% CI 17.03–23.39)
were detected positive for dengue IgG (secondary infection). A
Table 1
Dengue fever conﬁrmation by IgM and selected variables in the subjects of Khyber
Pakhtunkhawa
Parameters Total
patients
IgM positive 95% Conﬁdence
intervals
p-Value
Number of
participants
612 195 (31.86) 28.17–35.55 0.00
Gender
Male 489 173 (37.24) 32.96–41.52 0.06
Female 123 22 (17.88) 11.11–24.65
Residence
Urban 299 123 (41.13) 35.55–46.71 0.0005
Rural 313 72 (23) 18.34– 27.66
Age in years
10 25 6 (24) 7.26– 40.74
11–20 134 41 (30.59) 22.79–38.39
21–30 216 85 (39.35) 32.84–45.86 0.64
31–40 116 39 (33.62) 25.02– 42.22
41–50 51 15 (29.41) 16.91–41.91
51 71 18 (25.35) 15.23–35.47
History of travel to an endemic area
Yes 65 23 (35.38) 23.76–47 0.023
No 547 180 (33) 29.06–36.94
Table 3
Clinical signs and symptoms of dengue fever in selected subjects
Clinical
symptoms
Dengue-negative
patients, n = 294
Dengue-positive
patients, n = 319
p-Value
Fever 212 (72) 315 (98.74) 0.007
Headache 145 (49.31) 228 (71.47) 0.001
Skin rash 127 (43.19) 195 (61.12) 0.005
Joint pain 95 (32.31) 170 (53.29) 0.004
Fatigue 75 (25.51) 122 (48.27) 0.008
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95% CI 14.21–20.95) as compared to females (22.76%, 95% CI
16.86–27.98); no signiﬁcant difference was seen between genders
and IgG-positive subjects (p = 0.53). The incidence of IgG
antibodies was frequently higher in the age group of 21–30 years
(22.42%, 95% CI 16.86–27.98) as compared to the adolescent age
group 10 years and older people aged 51 years. No statistical
relationship was observed between age groups and IgG-positive
subjects (p = 0.49). The seroprevalence of IgG in infected patients
was higher in urban areas (27.41%, 95% CI 22.36–32.48) than in
rural areas (13.41%, 95% CI 9.63–17.19). Area of residence was
statistically associated with IgG-positive patients (p = 0.0007).
Most of the IgG antibodies were found positive in patients with a
history of travel to an endemic area (50.76%, 95% CI 38.61–62.91)
as compared to the distribution of IgG in diseased subjects having
no history of travel to an endemic area (15%, 95% CI 12.01–17.99).
Travel history was strongly associated with IgG-positive patients
(p = 0.041) (Table 2).
3.4. Clinical symptoms of dengue-infected patients
Table 3 shows the clinical signs and symptoms of dengue
patients; 98.74% of the patients had fever (p = 0.007), 71.47% of theTable 2
Dengue fever afﬁrmation by IgG and selected variables in the subjects of Khyber
Pakhtunkhawa
Parameters Total
patients
IgG positive 95% Conﬁdence
intervals
p-Value
Number of
participants
612 124 (20.21) 17.03–23.39 0.00
Gender
Male 489 96 (17.58) 14.21–20.95 0.53
Female 123 28 (22.76) 15.35–30.17
Residence
Urban 299 82 (27.42) 22.36–32.48 0.0007
Rural 313 42 (13.41) 9.63–17.19
Age in years
 10 25 4 (16) 1.63–30.37
11–20 134 17 (12.68) 7.05–18.31
21–30 216 49 (22.42) 16.86–27.98 0.49
31–40 116 22 (19) 11.86–26.14
41–50 51 9 (17.64) 7.18–28.1
51 71 14 (19.71) 10.46–28.96
History of travel to an endemic area
Yes 65 33 (50.76) 38.61–62.91 0.041
No 547 83 (15) 12.01–17.99patients had headache (p = 0.001), 61.12% of the patients experi-
enced skin rash (p = 0.005), 53.29% of the patients had joint pain
(p = 0.004), and 48.27% of the subjects were suffering from fatigue
(p = 0.008). All the clinical symptoms were statistically associated
with dengue fever.
3.5. Monthly distribution of dengue cases and deaths in year 2011 in
Khyber Pakhtunkhawa
A high incidence of dengue was observed in September
(n = 216), including four deaths. In October, 98 cases were detected
and two patients died; furthermore, ﬁve cases were diagnosed in
August and one death occurred (Figure 3).
3.6. Seasonal incidence of dengue fever in Khyber Pakhtunkhawa
The seasonal determination surveys demonstrated that the
post-monsoon period was the most affected period (n = 218,
68.33%), followed by the monsoon period (n = 101, 31.68%), and no
single positive case was noted in the pre-monsoon period
(Figure 4).
4. Discussion
This is the ﬁrst large-scale seroprevalence study of dengue
infection reported from Khyber Pakhtunkhawa Province of
Pakistan. Of the overall weighted prevalence of dengue-speciﬁc
IgM and IgG antibodies of 52.12% (n = 319), IgM was found positive
in 31.86% (n = 195) and IgG in 20.26% (n = 124) of patients. Our
seroprevalence of dengue antibodies is lower than that reported
from the epidemiological study conducted in Lahore, where the
incidence of IgM was 48.66% (n = 166) and IgG was 39.5% (n = 79),
but higher than that from the study conducted in Hyderabad, Sindh
where IgM was 16.47% (n = 28) and IgG was 12.35% (n = 21).12–19
The highest seroprevalence of IgM (n = 85, 39.35%) and IgG
(n = 49, 22.42%) antibodies was seen in the age group of 20–30
years as compared to the other age groups. This high prevalence of
dengue infection in the young age group of 20–30 years isFigure 3. Monthly distribution of dengue fever and deaths in Khyber
Pakhtunkhawa.
Figure 4. Seasonal occurrence of dengue cases in 2011.
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localities,20,21 but in contrast with a study conducted in Singapore
in which a higher prevalence of IgM and IgG antibodies were
observed in older aged people.22
A higher incidence of dengue IgM (n = 173, 37.24%) and IgG
(n = 96, 17.58%) antibodies was noted among males than females
(IgM n = 22, 17.88%; IgG n = 28, 22.76%), which is consistent with
other studies conducted in tropical/subtropical countries in which
males were found to be more susceptible to dengue than
females.4,23–26 This difference may be associated with disparities
in gender-speciﬁc contact, according to conﬁned intellectual
settings and daily activities in the outdoors. Disparity by gender
was not statistically signiﬁcant with IgM (p = 0.06) and IgG
(p = 0.53).
Dengue is noticed an urban disease and the deadly disease
partially attributed to gradually more populated towns in rural areas
as well.5 We identiﬁed dengue cases during the period of August–
October in 2011. Lower percentages of IgM (23%) and IgG (13.41%)
dengue antibodies were observed in rural areas compared to urban
areas (IgM 41.13% and IgG 27.42%), in concordance with the study of
Hayes et al. who found the dengue antibody seroprevalence to be
higher in urban populations as compared to rural populations.27
Residence was signiﬁcantly associated with IgM (p = 0.0005) and IgG
(p = 0.0007) positive subjects. In addition to expanding vector
numbers, improved routes of transportation allow the migration of
viremic humans from one region to another, which might facilitate
the spread of dengue from urban into rural areas.
This outbreak of dengue infection occurred mostly in the post-
monsoon period (n = 218, 68.33%) compared to the monsoon
period (n = 101, 31.68%), which is consistent with previous
outbreaks in Pakistan28 and in the neighboring country of India
as well.29 The post-monsoon season is a peak period for dengue
infection due to the high humidity after the rainy season, which
provides sufﬁcient breeding sites for mosquitoes.
In a study from Singapore, Low et al. reported that fever,
headache, joint pain, fatigue, and skin rashes were statistically
associated with dengue.30 Similarly, the majority of our entire
febrile cohort were symptomatic and symptoms were statistically
related to dengue infection. Fever, headache, joint pain, and
fatigue, as well as skin rashes were statistically linked with dengue
infection. Therefore the detection of a DENV infection should be
undertaken for patients who present with a wide variety of signs
and symptoms and who inhabit or have passed through a dengue
endemic area. Of the 319 patients who had a clinical diagnosis of
DENV infection, seven (2.19%) died and 312 (97.8%) recovered. All
seven of the patients who died presented with fever, fatigue,
headache, and skin rash.
One important ﬁnding of our study was that the seropreva-
lences of IgM (35.38%) and IgG (50.76%) antibodies were higher in
patients who presented a history of travel to an endemic area ascompared to the incidence in patients who presented no such
history (IgM 33% and IgG 15%). Moreover travel history was
signiﬁcantly associated with IgM (p = 0.023) and IgG (p = 0.041)
positive subjects. This observation suggests that the higher
prevalence could be because of the heavy load in the ﬂoating
population from the dengue epidemic areas of Pakistan where
dengue cases have been diagnosed previously,13–18 and currently
from Punjab where dengue infection hit a large population of
Lahore in 2011.31
These results are in agreement with those of several studies on
this topic. Dengue virus is increasingly recognized as the most
prevalent agent of febrile illness in travelers returning from dengue
epidemic areas.31–33 Familial outbreaks of dengue viral infection
introduced through travelers have to be regarded as a potential risk
in the non-endemic geographical areas in which competent
dengue vectors are already present.
The government and policy makers urgently need to make
extensive efforts towards disease prevention and vector control
through biological and/or environmental measures, chemical
measures, and education strategies in the community, so that
patients seek timely medical care, and knowledge of family
dispensers/physicians/general practitioners to identify the admis-
sion signs and symptoms of dengue viral infection is strengthened.
Moreover a strong campaign would be indispensable to increase
local awareness in the population of this area so that they follow all
the preventive measures against dengue infection to avoid further
spreading of the virus.
Finally there is an urgent need to conduct further seropreva-
lence studies on a large scale to determine the real magnitude of
the problem. The timely detection and regular management of this
condition can help to decrease the morbidity and mortality rates to
some extent; without due care, this situation could lead to
considerable dengue complications in the forms of DHF and DSS in
future episodes.
In conclusion, these results indicate a large earlier exposure of
the people of Khyber Pakhtunkhawa to dengue infection and
highlight the risks of febrile illness due to the prospect of dengue
virus. The present febrile cohort study showed that young people
and males are more disposed to dengue fever. Dengue infection
was most frequent in the post-monsoon season, in urban areas, and
in patients with a history of travel to an endemic area. Seven
patients died due to dengue fever in our infected population.
Further critical analysis is necessary to characterize the current
dengue virus circulation patterns and to identify the linked
serotypes and genotypes.
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